This data shows that PD mutations affect tau pathology in a mutation type specific manner, with both SNCA A53T and LRRK2 R1441G mutations having increased numbers of tau puncta in dopamine neurons, while PRKN lof did not display tau pathology. This evidence concerns the gene MAPT and Parkinson disease.